None of these have been formally tested with retatrutide+cagrilintide
Central and peripheral nervous system models in rats covering traumatic injury, stroke, and peripheral nerve transection, with cell-survival and tract-tracing endpoints
Full results were presented at the American Diabetes Associations 85th Scientific Sessions alongside the REDEFINE 1 data
Celiac Disease: Who Is at Increased Risk
Optimal Dosing & Administration (2025 Protocols) General Recovery: 250350 mcg subcutaneous (near injury site) once daily for 46 weeks
However, as reassuring as all of this is, there are a couple of things to remain mindful of: Copper toxicity Because GHK-Cu contains copper, it does pose a potential risk of copper toxicity,12 the symptoms of which include abdominal pain, vomiting, chest pain, chills, cough, fever, general weakness, anemia, burning sensations, tremors, and a metallic taste in the mouth.13 The risk is small, as the concentrations of copper in the peptide are typically well within safe parameters, but its good to be aware of it